1-6 of 6
Nikola Tom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

Clinical Trials & Observations
Jitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova, Lenka Radova, Karla Plevova, Jana Kotaskova, Karol Pal, Barbara Dvorackova, Marcela Zenatova, Jakub Hynst, Eva Ondrouskova, Anna Panovska, Yvona Brychtova, Kristyna Zavacka, Boris Tichy, Nikola Tom, Jiri Mayer, Michael Doubek, Sarka Pospisilova
Journal: Blood
Blood (2021) 138 (25): 2670–2685.
https://doi.org/10.1182/blood.2020009530
Published: 2021
Includes: Supplemental data
Journal Articles

Persistence of Mutations during Remission in 114 AML Patients

Martin Culen, PhD, Zdenka Kosarova, MSc, Ivana Jeziskova, PhD, Adam Folta, PhD, Nikola Tom, MSc, Ondrej Venglár, Dana Dvorakova, PhD, Jiri Mayer, MD, Zdenek Racil
Journal: Blood
Blood (2018) 132 (Supplement 1): 2796.
https://doi.org/10.1182/blood-2018-99-110586
Published: 2018
Journal Articles

Simulation of AML Clonality in Patient-Derived Xenografts

Zdenka Kosarova, MSc, Martin Culen, PhD, Ivana Jeziskova, PhD, Adam Folta, PhD, Veronika Janeckova, PhD, Jana Cerna, PhD, Tomas Loja, PhD, Nikola Tom, MSc, Lukas Semerad, MD, Zuzana Sustkova, MD, Dana Dvorakova, PhD, Jiri Mayer, Prof, MD SCs, Zdenek Racil, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3915.
https://doi.org/10.1182/blood.V130.Suppl_1.3915.3915
Published: 2017
Journal Articles

Low-Burden TP53 Mutations Occur in Chronic Phase of Myeloproliferative Neoplasms Regardless of Hydroxyurea Administration, Disease Type, and JAK2 Status

Blanka Kubesova, MSc, Sarka Pavlova, PhD, Jitka Malcikova, PhD, Jitka Kabathova, MSc, Lenka Radova, PhD, Nikola Tom, MSc, Boris Tichy, PhD, Karla Plevova, PhD, Barbara Kantorova, PhD, Kristyna Fiedorova, MSc, Jarmila Kissova, PhD, Bettina Gisslinger, Heinz Gisslinger, Jiri Mayer, MD, Robert Kralovics, Sarka Pospisilova, Michael Doubek
Journal: Blood
Blood (2016) 128 (22): 4284.
https://doi.org/10.1182/blood.V128.22.4284.4284
Published: 2016
Journal Articles

Prognostic Impact of NOTCH1 Hotspot Mutation in TP53 -Mutated Patients with Chronic Lymphocytic Leukemia

Barbara Kantorova, M.S., Jitka Malcikova, PhD, Veronika Navrkalova, M.S., PhD, Jana Smardova, Prof., MD PhD, Kamila Brazdilova, M.S., Karla Plevova, M.S., PhD, Eva Diviskova, M.S., Marek Borsky, M.S., Sarka Pavlova, M.S., PhD, Nikola Tom, M.S., Karol Pal, M.S., Martin Trbusek, Dr., PhD, Alexandra Oltova, Dr., Yvona Brychtova, MD PhD, Michael Doubek, Prof., MD PhD, Jiri Mayer, Prof., MD PhD, Sarka Pospisilova, Prof., Dr., PhD
Journal: Blood
Blood (2014) 124 (21): 3283.
https://doi.org/10.1182/blood.V124.21.3283.3283
Published: 2014
Journal Articles

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Barbara Kantorova, MSc., Jitka Malcikova, Dr., PhD., Jana Kminkova, PharmD., Veronika Navrkalova, MSc., Barbora Dvorakova, MSc., Boris Tichy, Dr., PhD., Jana Smardova, Prof., Martin Trbusek, Dr., PhD., Sim Truong, PhD., Katerina Stano-Kozubik, PhD., Nikola Tom, MSc., Karol Pal, MSc., Ludmila Sebejova, Dr., Nancy Patten, PhD., Lin Wu, PhD., Michael Doubek, M.D., PhD., Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 3911.
https://doi.org/10.1182/blood.V120.21.3911.3911
Published: 2012